Published in Drug Law Weekly, April 13th, 2004
Known as a technological innovator in the field of molecular genetics, Mello, of the University of Massachusetts Medical School, along with Andrew Fire, PhD, of Stanford University, is a key inventor on the first approved patent for the use of double stranded RNA for gene silencing, a technology that has come to be known as RNAi
RNAi has already become a groundbreaking tool for drug discovery that allows researchers to rapidly...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly